REGIONAL private healthcare provider Health Management International (HMI Group) is entering into a strategic partnership with Siemens Healthineers to advance the Malaysian healthcare industry and cultivate local talents surrounding the use of new medical technologies in their tertiary hospitals Mahkota Medical Centre (Mahkota) in Melaka and Regency Specialist Hospital (Regency) in Johor.
As part of this RM100 million five-year strategic partnership,which is the first-of-its-kind in Southeast Asia, HMI Group will partner Siemens Healthineers to roll out innovative medical technologies, digitalisation platforms and clinical services advancements across the Group including Mahkota and Regency in Malaysia.
Group CEO of HMI Group, Chin Wei Jia explained that the further development of CoEs in cancer, neuroscience and cardiovascular diseases as part of the strategic partnership and was in line with the Malaysian government’s goals to address the growing issue of non- communicable diseases (NCDs) and reduce premature mortality caused by NCDs by 2025.
The focus on these areas for the new Centres of Excellence also aligns with the nation’s NCD trends, as 35 per cent of NCD deaths are from cardiovascular diseases, followed by 16 per cent from cancers.
“This strategic partnership will enable Mahkota Medical Centre and Regency Specialist Hospital to improve patient care by serving as flagship reference sites for Siemens Healthineers in Southeast Asia,” shared Chin.
Established earlier this calendar year, this partnership with Siemens Healthineers signals the start of a long-term relationship between these two companies to advance healthcare delivery in Malaysia and the region.
“As our first reference site for Value Partnerships in Southeast Asia, HMI Group will demonstrate how healthcare consulting plays a critical role in developing meaningful partnerships to overcome the increasing challenges in the industry today,” said Rod Frazer, Managing Director, Siemens Healthineers, Malaysia.
“HMI Group is committed to not just improve the lives of our patients but the community, by developing local talents, continuous investment in innovative medical technologies, and further development of our Centres of Excellence.
“Even with Covid-19 still affecting Malaysia and many countries globally, we are confident that our investment towards advancing healthcare delivery in Malaysia will lead to better care for our patients and ultimately contribute to a better economy for the future,” said Chin.
